Recruiting studies: Oligoarthritis Juvenile

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis
Phase 3 · 7 location(s) · Amgen · NCT05767047 STep-up and Step-down Therapeutic Strategies in Childhood ARthritiS
Phase 3 · 1 location(s) · Istituto Giannina Gaslini · NCT03728478 A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With J
Phase 3 · 33 location(s) · AbbVie · NCT06100744 Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in
Phase 1 · 8 location(s) · Novartis Pharmaceuticals · NCT06751238 Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis
Phase 3 · 45 location(s) · Amgen · NCT04804553 A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With
Phase 3 · 47 location(s) · Bristol-Myers Squibb · NCT06869551 Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Phase N/A · 82 location(s) · Duke University · NCT02418442 A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Phase 3 · 47 location(s) · Janssen Research & Development, LLC · NCT06663332 An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Acti
Phase 3 · 23 location(s) · UCB Biopharma SRL · NCT06668181 A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
Phase 3 · 79 location(s) · Eli Lilly and Company · NCT03773965

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.